FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 56 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,346,800 | -24.3% | 185,000 | -15.9% | 0.83% | +8.1% |
| Q3 2022 | $1,780,000 | +81.6% | 220,000 | +10.0% | 0.77% | +40.5% |
| Q2 2022 | $980,000 | -79.3% | 200,000 | 0.0% | 0.55% | -75.3% |
| Q1 2022 | $4,730,000 | +33.7% | 200,000 | 0.0% | 2.21% | +48.6% |
| Q4 2021 | $3,538,000 | -61.1% | 200,000 | -38.0% | 1.49% | -53.7% |
| Q3 2021 | $9,098,000 | +43.7% | 322,500 | -46.6% | 3.21% | +26.9% |
| Q2 2021 | $6,331,000 | -13.7% | 604,074 | -3.0% | 2.53% | -4.3% |
| Q1 2021 | $7,333,000 | -8.2% | 622,500 | -8.8% | 2.64% | +21.6% |
| Q4 2020 | $7,992,000 | +164.2% | 682,500 | +78.9% | 2.18% | +164.6% |
| Q3 2020 | $3,025,000 | – | 381,500 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
| COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
| RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
| RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
| Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
| Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
| Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
| DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |